Commonwealth Equity Services’s Atossa Therapeutics ATOS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $38K | Hold |
46,001
| – | – | ﹤0.01% | 4183 |
|
2025
Q1 | $31K | Hold |
46,001
| – | – | ﹤0.01% | 4102 |
|
2024
Q4 | $43K | Buy |
46,001
+9,978
| +28% | +$9.33K | ﹤0.01% | 3992 |
|
2024
Q3 | $55K | Buy |
36,023
+10,000
| +38% | +$15.3K | ﹤0.01% | 3924 |
|
2024
Q2 | $31K | Sell |
26,023
-280
| -1% | -$334 | ﹤0.01% | 3933 |
|
2024
Q1 | $47K | Sell |
26,303
-7,042
| -21% | -$12.6K | ﹤0.01% | 3900 |
|
2023
Q4 | $29K | Hold |
33,345
| – | – | ﹤0.01% | 3796 |
|
2023
Q3 | $25K | Sell |
33,345
-1,260
| -4% | -$945 | ﹤0.01% | 3717 |
|
2023
Q2 | $44K | Buy |
34,605
+50
| +0.1% | +$64 | ﹤0.01% | 3676 |
|
2023
Q1 | $25 | Sell |
34,555
-3,750
| -10% | -$3 | ﹤0.01% | 3651 |
|
2022
Q4 | $20K | Buy |
38,305
+10,022
| +35% | +$5.23K | ﹤0.01% | 3597 |
|
2022
Q3 | $23K | Sell |
28,283
-2,000
| -7% | -$1.63K | ﹤0.01% | 3561 |
|
2022
Q2 | $33K | Hold |
30,283
| – | – | ﹤0.01% | 3530 |
|
2022
Q1 | $37K | Sell |
30,283
-159
| -0.5% | -$194 | ﹤0.01% | 3613 |
|
2021
Q4 | $48K | Buy |
30,442
+2,000
| +7% | +$3.15K | ﹤0.01% | 3536 |
|
2021
Q3 | $92K | Sell |
28,442
-4,941
| -15% | -$16K | ﹤0.01% | 3436 |
|
2021
Q2 | $210K | Buy |
33,383
+2,000
| +6% | +$12.6K | ﹤0.01% | 3231 |
|
2021
Q1 | $66K | Buy |
+31,383
| New | +$66K | ﹤0.01% | 3315 |
|
2016
Q3 | – | Sell |
-40,000
| Closed | -$11K | – | 2257 |
|
2016
Q2 | $11K | Hold |
40,000
| – | – | ﹤0.01% | 2218 |
|
2016
Q1 | $14K | Buy |
+40,000
| New | +$14K | ﹤0.01% | 2179 |
|